Seres is developing live biotherapeutics aimed at modulating immune function and promoting protective responses in vulnerable patients, including those with chronic inflammatory. Seres’ pioneering science, paired with powerful drug development and manufacturing capabilities, underpins its unique platform. Mcrb), (seres or the company), a leading live biotherapeutics company, today announced. Seres therapeutics is a clinical stage biotechnology company developing new therapies comprised of rationally selected live bacteria consortia. We have a strong development. Seres will present at the 42 nd annual j. p. Morgan healthcare conference on wednesday, january 10, 2024, at 12:45 pm et / 9:45 am pt. The live presentation and.

-